Compositions and methods for treating pests
US-2015373994-A1 · Dec 31, 2015 · US
US11089785B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11089785-B2 |
| Application number | US-201616070703-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 20, 2016 |
| Priority date | May 22, 2015 |
| Publication date | Aug 17, 2021 |
| Grant date | Aug 17, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Anti-microbial metabolites secreted from various bacterial and/or fungal species are described that have anti-bacterial activity against Xanthomonas species, which cause disease in plant hosts, including a wide variety of crops. Bacterial and fungal species producing such metabolites were identified from environmental samples (seeds, different vegetable organs and soil) from different geographic locations. Compositions, methods, uses, and kits 5 relating to the identified anti-microbial metabolites are also described.
Opening claim text (preview).
The invention claimed is: 1. A biopesticide having antimicrobial activity against phytopathogenic Xanthomonas species, said biopesticide consisting of Bacillus amyloliquefaciens subsp. plantarum 71 (NRRL B-67021) and metabolites thereof, and one or more agriculturally acceptable excipients, wherein said metabolites comprise polyketide metabolites bacillaene, difficidin, and macrolactin. 2. The biopesticide of claim 1 , wherein said metabolites are extracellular bacterial metabolites. 3. The biopesticide of claim 1 , wherein said biopesticide has antimicrobial activity against Xanthomonas campestris, Xanthomonas perforans, Xanthomonas gardneri , or any combination thereof. 4. The biopesticide of claim 1 , wherein said antimicrobial activity comprises antagonistic activity. 5. The biopesticide of claim 1 , wherein said metabolites comprise lipopeptides and/or siderophores having anti- Xanthomonas activity. 6. The biopesticide of claim 5 , wherein said lipopeptides are non-ribosomal lipopeptides (NRPs). 7. The biopesticide of claim 5 , wherein said lipopeptides and/or siderophores comprise surfactin, fengycin, iturin, bacilysin, and bacillibactin, or any combination thereof. 8. The biopesticide of claim 1 , wherein said metabolites further comprise bacillaene, difficidin, macrolactin, kalimantacin/batumin, plantathiazolicin/plantazolicin, and bacteriocin, or any combination thereof. 9. The biopesticide of claim 1 , wherein the agriculturally acceptable excipient comprises a non-toxic carrier, surfactant, preservatives, nutrients, UV protectant, sticker, spreader, and/or chelating agent. 10. The biopesticide of claim 1 , wherein said composition is in the form of a liquid, concentrate, powder, tablet, gel, pellets, granules, or any combination thereof. 11. A method for controlling the growth of a pathogenic microorganism on a target plant or tissue, said method comprising contacting said target plant or tissue with the biopesticide of claim 1 . 12. A method for producing the biopesticide of claim 1 , the method comprising culturing viable cells of Bacillus amyloliquefaciens subsp. plantarum 71 (NRRL B-67021) under conditions enabling the production of said metabolites; harvesting and/or concentrating said metabolites produced from said viable cells; and formulating said metabolites to produce said biopesticide.
Related publications grouped by family.
Answers are generated from the same data shown on this page.